Getting the right starting material is crucial to developing your CAR-T and other cell immunotherapies. Excellos will deliver your specified cell types, healthy and ready for scale-up, under cGMP conditions. With over 250K active blood donors you get the diversity and selections that match your requirements, without costly new donor characterization. Want more? Using our network (including San Diego Blood Bank) we can rapidly expand your collection.
With your customized donor samples collected, Excellos can enrich, isolate, and preserve specified cell populations. These screened cell populations are ready for genetic modification by transfection/transduction. Isolated immune cells commonly specified may include T-cells, Natural Killer cells (NK), or CD34+ cells.
Ready to go deeper on cell characterization? Advance past typical cell and donor screening to create a comprehensive immune cell profile for each donor as well as an assessment of the metabolic and effector potential of their cells. See beyond surface markers too.
Now that you have the best donated cellular material, it is time to optimize your cell therapy process for GMP manufacturing. We offer R&D services including process development and GMP production for Phase I through Commercial manufacturing.
With Excellos Quality Assurance (QA) and Regulatory teams at your side, you get standardized procedures, control measures, and documentation that delivers a consistent, reproducible product to meet regulatory requirements.